William Blair analyst Tim Lugo initiates coverage on Atea Pharmaceuticals (NASDAQ: AVIR) with an Outperform rating.The analyst commented, "Atea is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE